Results 1 to 10 of about 25,813 (258)

Preoperative Low-Density Lipoprotein Apheresis for Preventing Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation

Journal of Transplantation, 2018
Background. Focal segmental glomerulosclerosis (FSGS) often develops rapidly and frequently progresses to renal failure, while the recurrence rate after kidney transplantation is 20–50%.
Akihito Sannomiya, Toru Murakami, Ichiro Koyama, Kosaku Nitta, Ichiro Nakajima, Shohei Fuchinoue   +5 more
doaj   +1 more source

Proton pump inhibitors may hinder hypophosphatemic effect of lanthanum carbonate, but not of ferric citrate hydrate or sucroferric oxyhydroxide, in hemodialysis patients

Renal Failure, 2020
Because end-stage renal disease patients undergoing hemodialysis frequently take acid suppressants for the treatment or prevention of gastrointestinal diseases, it is important to clarify the drug-interactions between acid suppressants and phosphate ...
Hitoshi Minakuchi, Tadashi Yoshida, Noriko Kaburagi, Teppei Fujino, Sho Endo, Tomoko Yamashita Takemitsu, Norimasa Yamashita, Hiroshi Itoh, Mototsugu Oya   +8 more
doaj   +1 more source

Activated Platelets and Platelet-Derived Extracellular Vesicles Mediate COVID-19-Associated Immunothrombosis

Frontiers in Cell and Developmental Biology, 2022
Activated platelets and platelet-derived extracellular vesicles (EVs) have emerged as central players in thromboembolic complications associated with severe coronavirus disease 2019 (COVID-19).
Marie Ebeyer-Masotta, Tanja Eichhorn, René Weiss, Lucia Lauková, Viktoria Weber   +4 more
doaj   +1 more source

Assessing Knowledge, Public Awareness, and Confidence Assurance of Apheresis Donors among Blood Bank Donors in Tobruk, Libya.

Tobruk University Journal of Medical Sciences
Background: Blood donation is a critical component of healthcare, and apheresis has emerged as an advanced technique for collecting specific blood components, such as platelets, plasma, and red blood cells. Despite its advantages, apheresis remains less
Alkadafe Agelah, Hanan Mahdi
doaj   +1 more source

Therapeutic Plasma Exchange - An Emerging Treatment Modality in Patients with Neurologic and Non-Neurologic Diseases [PDF]

Journal of Clinical and Diagnostic Research, 2017
Introduction: Therapeutic Plasma Exchange (TPE) is a procedure in which the patient’s blood is passed through an apheresis machine, where the filtered plasma is removed and discarded with reinfusion of red blood cells along with replacement fluid ...
Shreedevi S Bobati, Karkal Ravishankar Naik   +1 more
doaj   +1 more source

The unusual case of babesiosis causing disseminated intravascular coagulation with hemophagocytic lymphohistiocytosis

Clinical Case Reports, 2021
Babesiosis is increasing in the elderly due to an age‐related decline in immunity. Prompt diagnosis with blood smear and PCR prevent life‐threatening complications, like DIC and HLH. Studies focusing on pathophysiology and risk factors are needed.
Alexandra Goodman, Musa Bilal, Shivantha Amarnath, Teresa Gentile, Zachary Shepherd   +4 more
doaj   +1 more source

Outcomes of therapeutic plasma exchange: A 15-year tertiary center experience

Iraqi Journal of Hematology, 2023
BACKGROUND: Therapeutic plasma exchange (TPE) is a treatment option used in many medical conditions. Response rates are variable as some disorders clearly benefit from TPE as first- or second-line therapy.
Salwa Hindawi, Osman Radhwi, Maha Badawi, Hanaa Rajab, Fatma Al Mansouri, Ali Alzahrani, Hussam Bukhari, Kholoud Gholam, Ahmad Almalki, Abdulaziz Awadh, Ismat Khalil Yagoub, Galila Zaher   +11 more
doaj   +1 more source

Lipoprotein apheresis to treat elevated lipoprotein (a)1

Journal of Lipid Research, 2016
An elevated plasma concentration of lipoprotein (a) [Lp(a)] is an independent risk factor for cardiovascular disease. Life style modification and currently available drugs either fail to effectively lower plasma Lp(a) levels or do not result in clinical ...
Elisa Waldmann, Klaus G. Parhofer
doaj   +1 more source

Urinary Neopterin and Microalbuminuria in Patients Treated by Low-density Lipoprotein Apheresis

Pteridines, 2005
Low-density lipoprotein (LDL)-apheresis is a method of extracorporeal elimination of LDL-cholesterol in patients with severe primary lipoprotein disorders.
Cermanová Melanie, Melichar Bohuslav, Solichová Dagmar, Bláha Milan, Bláha Vladimir, Blazek Martin, Mašín Vladimir, Cerman Jaroslav, Zadák Zdenek   +8 more
doaj   +1 more source

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundApheresis is an important treatment for reducing low‐density lipoprotein cholesterol (LDL‐C) in patients with familial hypercholesterolemia (FH). We systematically reviewed the current literature surrounding LDL‐C apheresis for FH.
Anthony Wang, Akshara Richhariya, Shravanthi R. Gandra, Brian Calimlim, Lisa Kim, Ruben G. W. Quek, Robert J. Nordyke, Peter P. Toth   +7 more
doaj   +1 more source